ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells-Reference-Cited by-同舟云学术

ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells

Published:2017-12 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Wang Hongsheng,Gonzalez-Garcia Ines,Traba Javier,Jain Shweta,Conteh Solomon,Shin Dong-Mi,Qi Chenfeng,Gao Yuanyuan,Sun Jiafang,Kang Sungyun,Abbasi Sadia,Naghashfar Zohreh,Yoon Jeongheon,DuBois Wendy,Kovalchuk Alexander L.,Sack Michael N.,Duffy Patrick^ORCID,Morse Herbert C.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-18028-z.pdf

Reference66 articles.

1. Jacob, J., Kassir, R. & Kelsoe, G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med 173, 1165–1175 (1991).

2. Smith, K. G., Weiss, U., Rajewsky, K., Nossal, G. J. & Tarlinton, D. M. Bcl-2 increases memory B cell recruitment but does not perturb selection in germinal centers. Immunity 1, 803–813 (1994).

3. Sze, D. M., Toellner, K. M., Garcia de Vinuesa, C., Taylor, D. R. & MacLennan, I. C. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med 192, 813–821 (2000).

4. Ho, F., Lortan, J. E., MacLennan, I. C. & Khan, M. Distinct short-lived and long-lived antibody-producing cell populations. Eur J Immunol 16, 1297–1301 (1986).

5. Manz, R. A. & Radbruch, A. Plasma cells for a lifetime? Eur J Immunol 32, 923–927 (2002).

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of VH domains that allosterically inhibit ENPP1;Nature Chemical Biology;2023-07-03

2. An atlas of the bone marrow bone proteome in patients with dysproteinemias;Blood Cancer Journal;2023-04-28

3. A2AR as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma;International Journal of Molecular Sciences;2023-04-03

4. An atlas of the bone marrow bone proteome in patients with dysproteinemias.;2023-01-23

5. S evere acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study;Diabetes, Obesity and Metabolism;2022-09-15